- Home
- KBDC vs OPK Comparison
KBDC vs OPK Comparison
Compare KBDC & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KBDC | OPK |
|---|---|---|
| Founded | 2021 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | KBDC | OPK |
|---|---|---|
| Price | $14.71 | $1.37 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $15.80 | $2.28 |
| AVG Volume (30 Days) | 435.5K | ★ 3.9M |
| Earning Date | 03-02-2026 | 02-26-2026 |
| Dividend Yield | ★ 12.93% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $642,067,000.00 |
| Revenue This Year | $193.84 | N/A |
| Revenue Next Year | $9.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.06 | $1.11 |
| 52 Week High | $17.99 | $2.04 |
Technical Indicators
Market Signals| Indicator | KBDC | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 47.65 | 57.15 |
| Support Level | $14.13 | $1.24 |
| Resistance Level | $14.80 | $1.38 |
| Average True Range (ATR) | 0.34 | 0.05 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 37.50 | 88.89 |
Price Performance
Historical ComparisonAbout KBDC Kayne Anderson BDC Inc.
Kayne Anderson BDC Inc is an externally managed, closed-end, non-diversified management investment company that has elected to be regulated as a business development company that invests primarily in first-lien senior secured loans, with a secondary focus on unitranche and split-lien loans to middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation primarily through debt investments in middle-market companies.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.